Humacyte Announces VASA Presentation on ATEV Self-Repair
Humacyte presented research at the VASA meeting demonstrating that its acellular tissue engineered vessel (ATEV) maintains structural integrity and self-repairs after repeated cannulations for dialysis access. The ATEV showed evidence of smooth muscle cell repopulation and reduced infection risk compared to ePTFE grafts, supporting its potential as a durable and infection-resistant option for long-term hemodialysis.
– Dialysis access requires frequent cannulation, often exceeding 300 needle punctures annually –
